News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,168 Results
Type
Article (86141)
Company Profile (649)
Press Release (752378)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232239)
Career Advice (4126)
Deals (39710)
Drug Delivery (126)
Drug Development (90811)
Employer Resources (198)
FDA (18006)
Job Trends (17325)
News (395602)
Policy (39676)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2992)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (80)
Alliances (56665)
ALS (80)
Alzheimer's disease (1471)
Antibody-drug conjugate (ADC) (145)
Approvals (17995)
Artificial intelligence (225)
Autoimmune disease (27)
Automation (12)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (447)
Bladder cancer (76)
Brain cancer (26)
Breast cancer (232)
Cancer (2042)
Cardiovascular disease (145)
Career advice (3532)
Career pathing (34)
CAR-T (160)
Cell therapy (447)
Cervical cancer (17)
Clinical research (72852)
Collaboration (787)
Compensation (444)
Complete response letters (28)
COVID-19 (2830)
CRISPR (43)
C-suite (222)
Cystic fibrosis (99)
Data (1872)
Decentralized trials (2)
Denatured (45)
Depression (38)
Diabetes (187)
Diagnostics (6760)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (119)
Drug pricing (96)
Drug shortages (17)
Duchenne muscular dystrophy (83)
Earnings (95370)
Editorial (36)
Employer branding (25)
Employer resources (167)
Events (128546)
Executive appointments (619)
FDA (18958)
Featured Employer (63)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (649)
Gene editing (99)
Generative AI (22)
Gene therapy (319)
GLP-1 (738)
Government (5109)
Grass and pollen (4)
Guidances (38)
Healthcare (20744)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (132)
Indications (25)
Infectious disease (2947)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (43)
Intellectual property (86)
Interviews (812)
IPO (17691)
IRA (38)
Job creations (5186)
Job search strategy (2861)
Kidney cancer (11)
Labor market (41)
Layoffs (542)
Leadership (22)
Legal (10057)
Liver cancer (72)
Lung cancer (295)
Lymphoma (137)
Machine learning (6)
Management (65)
Manufacturing (290)
MASH (69)
Medical device (14301)
Medtech (14306)
Mergers & acquisitions (22284)
Metabolic disorders (599)
Multiple sclerosis (77)
NASH (22)
Neurodegenerative disease (102)
Neuropsychiatric disorders (25)
Neuroscience (1972)
NextGen: Class of 2025 (7666)
Non-profit (5058)
Northern California (2337)
Now hiring (40)
Obesity (321)
Opinion (272)
Ovarian cancer (69)
Pain (68)
Pancreatic cancer (63)
Parkinson's disease (133)
Partnered (21)
Patents (197)
Patient recruitment (94)
Peanut (48)
People (64903)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22508)
Phase II (31672)
Phase III (23816)
Pipeline (1037)
Policy (142)
Postmarket research (3542)
Preclinical (10146)
Press Release (72)
Prostate cancer (90)
Psychedelics (34)
Radiopharmaceuticals (251)
Rare diseases (364)
Real estate (7384)
Recruiting (75)
Regulatory (26445)
Reports (55)
Research institute (2647)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (5)
RSV (36)
Schizophrenia (70)
Series A (126)
Series B (72)
Service/supplier (25)
Sickle cell disease (46)
Southern California (1993)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (4287)
State (2)
Stomach cancer (11)
Supply chain (51)
Tariffs (37)
The Weekly (82)
United States (19995)
Vaccines (734)
Venture capitalists (41)
Weight loss (230)
Women's health (37)
Worklife (19)
Date
Today (188)
Last 7 days (747)
Last 30 days (2268)
Last 365 days (29118)
2025 (8774)
2024 (34072)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (54)
Alaska (6)
Arizona (245)
Arkansas (8)
Asia (49852)
Australia (8796)
California (5329)
Canada (1585)
China (497)
Colorado (168)
Connecticut (215)
Delaware (133)
Europe (114097)
Florida (666)
Georgia (147)
Hawaii (1)
Idaho (64)
Illinois (450)
India (25)
Indiana (270)
Iowa (10)
Japan (134)
Kansas (111)
Kentucky (16)
Louisiana (8)
Maine (59)
Maryland (839)
Massachusetts (4205)
Michigan (183)
Minnesota (310)
Mississippi (1)
Missouri (54)
Montana (24)
Nebraska (26)
Nevada (54)
New Hampshire (50)
New Jersey (1527)
New Mexico (27)
New York (1508)
North Carolina (1005)
North Dakota (8)
Northern California (2337)
Ohio (163)
Oklahoma (13)
Oregon (45)
Pennsylvania (1132)
Puerto Rico (12)
Rhode Island (24)
South America (1648)
South Carolina (4)
South Dakota (1)
Southern California (1993)
Tennessee (30)
Texas (698)
Utah (115)
Virginia (103)
Washington D.C. (39)
Washington State (515)
West Virginia (1)
Wisconsin (40)
839,168 Results for "peak bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bankruptcy
Biopharma Bankruptcies Still At Peak, With Little Relief in Sight
2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.
February 19, 2025
·
5 min read
·
Annalee Armstrong
Deals
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
Akari Therapeutics, Plc and Peak Bio Inc. announced completion of a joint portfolio prioritization review pursuant to which the combined entity, following completion of the previously announced merger of Akari and Peak, will focus on Peak’s ADC platform technology and Akari’s PAS-nomacopan Geographic Atrophy program.
May 1, 2024
·
16 min read
Press Releases
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
April 17, 2025
·
2 min read
Press Releases
Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger
November 8, 2024
·
12 min read
Press Releases
Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
November 15, 2024
·
8 min read
Deals
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
Akari Therapeutics, Plc and Peak Bio Inc. announce a definitive agreement to merge as equals in an all-stock transaction.
March 5, 2024
·
17 min read
Biotech Bay
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
Akari Therapeutics, Plc and Peak Bio Inc., a clinical-stage biopharmaceutical company focused on developing therapeutics in areas of inflammation and oncology announce a definitive agreement to merge as equals in an all-stock transaction.
March 5, 2024
·
17 min read
Biotech Bay
Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing
Peak Bio, Inc. (“Peak Bio” or the “Company”) (OTCQB) PK: PKBO), announced that it was awarded US Patent No. 11,691,982 B2 entitled “Thailanstatin Analogs” by The United States Patent and Trademark Office (USPTO).
January 4, 2024
·
7 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Immuron CEO Steven Lydeamore to present at Peak Sky High
Immuron Limited, an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will be presenting at Peak Asset Management’s Peak Sky High luncheon in Melbourne on June 1, 2024.
May 31, 2024
·
6 min read
1 of 83,917
Next
